Clinical Trial Update: Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the addition of rituximab to leflunomide in patients with active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide (Leflunomide)
• Rituximab (rituximab)

Snippet

Sponsor: Frank Behrens | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED